Anthony Blanchard, DPM
Foot & Ankle Surgery · West Chester, OHNPI 1497909741
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $19,577 of the $24,736 with a category attached, or 79.1%. Merck accounts for 92.7% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $23,972 and has fallen 99.4% since, to $136 in 2025.
Across 50 payments — averaging $494.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$23K
- Gemini Medical LLC$460
- Stryker$345
- Organogenesis Inc.$258
- Johnson & Johnson$137
- Pacira Pharmaceuticals Incorporated$120
- plus $497 from 9 others
What the payments were for
- Speaking & faculty fees$19,57779%
- Travel & lodging$3,15813%
- Food & beverage$1,5416%
- Education$4602%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 20 | $22,918 |
| Gemini Medical LLC | 1 | $460 |
| Stryker | 7 | $345 |
| Organogenesis Inc. | 3 | $258 |
| Johnson & Johnson(2 entities) | 7 | $137 |
| Pacira Pharmaceuticals Incorporated | 1 | $120 |
| Fusion Orthopedics USA, LLC | 1 | $103 |
| Polarityte, Inc. | 1 | $101 |
| Medtronic | 1 | $99 |
| Treace Medical Concepts, Inc. | 2 | $60 |
| Zimmer Biomet | 1 | $56 |
| Smith+Nephew | 2 | $36 |
| KCI USA, Inc. | 1 | $16 |
| Integra Lifesciences Corporation | 1 | $14 |
| Axogen | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SIVEXTRO$22,842
- Apligraf$243
- Dermagraft$243
- Puraply/Affinity/NuTech$243
- ASNIS$168
- VARIAX$168
- CANNULATE SCREW SYSTEM$130
- EXPAREL$120
- SkinTE$101
How this compares
$24,736 in reported general payments places this provider in the 85th percentile of 429 foot & ankle surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gentamicin Sulfate | 11 | $734 |
| Doxycycline Monohydrate | 17 | $333 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 34 | $283 |
| Cephalexin | 31 | $168 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 22 | $110 |
| Doxycycline Hyclate | 19 | $97 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $87 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in West Chester
- Matthew HamiltonWest Chester$26K
- Christopher HyerWorthington$4.7M
- Thomas LeePickerington$4M
- Jordan GrossmanAkron$2.5M
- Robert GorslineHilliard$1.4M
- Jonathan FeibelGahanna$1.4M
- Mark PrisselWorthington$1.2M
- Lee HladGahanna$440K
- Windy ColeKent$431K
- Elizabeth HewittGrove City$414K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.